20.11.2024
Helsinki, Finland, 20 November 2024 – MVision AI, a leading innovator in AI-driven solutions for oncology, is proud to announce its recognition among the top ten companies in the Deloitte Technology Fast 50 Finland 2024 ranking. This prestigious award acknowledges MVision AI's rapid growth and its mission-driven advancements in making…
Press Releases
24.10.2024
Helsinki, October 2024 – MVision AI, a leading innovator in AI-powered solutions for radiotherapy, is thrilled to announce that its auto-contouring solution Contour+ has received FDA 510(k) clearance for three new models: Bones CT, Brain MR, and Male Pelvis MR T2, and five updated models: Brain CT, Abdomen & Lung…
11.10.2024
Helsinki, Finland, October 11, 2024 – Baylor College of Medicine and MVision AI have entered into a strategic research and development agreement to drive innovation in radiation therapy through AI technology. This collaboration aims to accelerate the clinical adoption of AI-powered solutions, enhancing the efficiency and effectiveness of cancer treatment.…
6.8.2024
HELSINKI, Finland – August, 2024 MVision AI is excited to announce that our application for MVision AI Segmentation (Contour+) has been approved by the Central Drugs Standard Control Organization (CDSCO) under the “Image Segmentation Application Software” category. This approval facilitates the deployment of our advanced image analysis algorithms in radiation…
14.6.2024
Helsinki, Finland – June 14, 2024 – MVision AI, a pioneering company in the development of innovative AI solutions for radiation oncology is pleased to announce the appointment of Antti Pirskanen as its new Chief Financial Officer (CFO). Antti will assume his responsibilities immediately, bringing extensive expertise in financial management…
HELSINKI, Finland – June 14, 2024 MVision AI is pleased to announce that our application for MVision AI Segmentation (Contour+) in South Korea has been accepted by the Ministry of Food and Drug Safety (MFDS) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation…
1.5.2024
HELSINKI, Finland - May 1, 2024 An application for MVision AI Segmentation (Contour+) has been submitted and accepted by the Therapeutic Goods Administration (TGA) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation therapy treatment planning workflows. Contour+ accelerates the contouring process, provides guidance…
29.4.2024
Helsinki, Uusimaa - April 29, 2024 – MVision AI, a pioneering company in developing innovative AI solutions in the radiation oncology & imaging space, proudly announces the appointment of Dharanipathy Rangaraj as its new Chief Executive Officer (CEO). In his new capacity as CEO of MVision AI, Dharani will spearhead…
19.2.2024
Finland, Helsinki, February 19, 2024 The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI's successful award of the tender from the Republic…
22.1.2024
HELSINKI, Finland - January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL)…
HELSINKI, Finland - January 22, 2024 MVision AI announces first Health Canada Medical Device License for MVision AI Segmentation (Contour+). In conjunction with Guide and Verify, Contour+ stands as a unique solution covering all the essential needs of radiotherapy departments, offering a more comprehensive approach to staff training and patient…
24.11.2023
HELSINKI, Finland - November 24, 2023 Institut de CancĂ©rologie de Lorraine (ICL) in Nancy (France) has been a MVision AI customer since the installation of Contour+ in January 2023. This year, the values of using Guideline-Based AI Segmentation in daily practice have been prominently featured in several French media outlets…
Subscribe to get information, latest news and other interesting offers about MVision AI
